BRCA2 mutation status did not appear to correlate with a distinct clinicopathological phenotype or disease behaviour, and a strong trend was seen within BRCA2 carrier tumours containing areas of micropapillary carcinoma possible suggesting a possible BRCA2 male breast cancer phenotype. This evidence concerns the gene BRCA2 and breast carcinoma.